Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC
Clinical trial NCT07432984 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07432984
- Sponsor
- Se-Hoon Lee
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-10-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.